Photons as a 21st century reagent

Holly E. Bonfield, Thomas Knauber, François Lévesque, Eric G. Moschetta, Flavien Susanne and Lee J. Edwards ()
Additional contact information
Holly E. Bonfield: GSK
Thomas Knauber: Pfizer, Inc.
François Lévesque: Merck & Co., Inc.
Eric G. Moschetta: AbbVie, Inc.
Flavien Susanne: GSK
Lee J. Edwards: GSK

Nature Communications, 2020, vol. 11, issue 1, 1-4

Abstract: A pharmaceutical industry viewpoint on how the fundamental laws of photochemistry are used to identify the parameters required to implement photochemistry from lab to scale. Parameters such as photon stoichiometry and light intensity are highlighted within to inform future publications.

Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-019-13988-4 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:11:y:2020:i:1:d:10.1038_s41467-019-13988-4

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-019-13988-4

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().